• 01.10.2019 – 09:33

  Mindtree

  Mindtree Honored With Mother Teresa Award

  Bangalore, India (ots/PRNewswire) - Recognized for its industry leading practices in driving social impact Mindtree, a global technology services and digital transformation company, has been awarded the prestigious Mother Teresa Award for Corporate Citizen in recognition of its efforts towards elevating humanity through business. The Loyola Institute of Business Administration (LIBA) presented the award to Mindtree in ...

• 17.06.2019 – 10:00

  Deutschland - Land der Ideen

  For a better future: The winners of the international competition "beyond bauhaus - prototyping the future"

  Berlin (ots) - Nearly 1.500 applicants from 50 countries responded to the "Germany - Land of Ideas" initiative call for submissions. Berlin, 17 June 2019 - The initiative "Germany - Land of Ideas" is proud to announce the twenty winners of the international competition beyond bauhaus - prototyping the future. They ...

• 13.12.2018 – 16:06

  OD-OS GmbH

  

  APVRS 2018: Intuitive Iridotomy Treatment with the Navilas® 577s Retina Laser Released by OD-OS

• 28.11.2018 – 13:34

  LEH Pharma

  New Data Indicate That EyeMax Mono, a Lens Tailored Specifically for Patients With Dry Age-related Macular Degeneration (AMD), Offers Significant Improvement in Visual Function

  London (ots/PRNewswire) - EyeMax Mono implantation results in an improved mean visual acuity of 18 ETDRS letters and 57% increase in mean reading speed LEH Pharma Ltd, a leading provider of innovative technologies for macular disorders, today announces new data published in the Journal of Refractive Surgery[1], ...

• 06.11.2018 – 09:02

  Primary Care Diabetes Europe (PCDE)

  Primary Care Diabetes Europe Issues Call to Action Against Clinical Inertia in the Treatment of Type-2 Diabetes

  Ekeren, Belgium (ots/PRNewswire) - Research identifies lack of primary care physician adherence to treatment guidelines among the challenges to optimal care for patients with type-2 diabetes Primary Care Diabetes Europe (PCDE) today issued a call to action challenging primary care physicians and other healthcare ...

• 11.09.2018 – 14:31

  Merck KGaA

  BAVENCIO® (avelumab) Plus INLYTA® (axitinib) Significantly Improved Progression-Free Survival in Previously Untreated Patients With Advanced Renal Cell Carcinoma in Phase III Study

  Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media - First positive Phase III immunotherapy trial in combination with a tyrosine kinase inhibitor (TKI) in any tumor type - Results significant in both PDL1+ and all-comer populations - Alliance plans to pursue a ...